Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. us virgislands
  4. clinical data
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Events
Downloads
Videos

Refine by
Date

  • Older

Clinical Data Articles & Analysis

111 articles found

Monodispersed PEG Linkers Enhance Antibody–Drug Conjugates (ADCs)

Monodispersed PEG Linkers Enhance Antibody–Drug Conjugates (ADCs)

In fact, PEGylated linkers allow higher drug-to-antibody ratios (DARs) by preventing payload aggregation and rapid clearance. Clinical data show that ADCs with very high DARs (over ~6) clear quickly due to hydrophobicity, whereas optimized DARs (2–4) strike a balance of potency and half-life. ...

ByBiopharma PEG Scientific Inc


How Lipid Metabolism Fuels Steroid Hormones and Why Their Analysis Matters

How Lipid Metabolism Fuels Steroid Hormones and Why Their Analysis Matters

(2) Evaluate Experimental Interventions: In preclinical studies, steroid hormone profiling helps researchers assess the effects of potential therapeutic compounds on hormone pathways, providing crucial data before clinical translation. (3) Understand Pathophysiological Mechanisms: Research into the subtle changes in steroid hormone profiles can ...

ByCreative Proteomics


How Predictive Analytics is Boosting Clinical Trials Efficiency?

How Predictive Analytics is Boosting Clinical Trials Efficiency?

Clinical trials are the backbone of modern medicine, responsible for bringing innovative, safe, and efficient treatments to market after rigorous testing and evaluation. However, the conventional process of conducting these trials has often been long, expensive, and fraught with inefficiencies¹. The advent of predictive analytics is reshaping the landscape of clinical trials, ushering in a ...

BySOPHiA Genetics


The Importance of Data Diversity to Enhance Clinical Trials Success

The Importance of Data Diversity to Enhance Clinical Trials Success

Medical advancement relies on clinical trials, which are essential for the development of safe and effective innovative treatments. ...

BySOPHiA Genetics


How to Submit Sequence Data to GenBank   

How to Submit Sequence Data to GenBank  

Submission of sequence data to NCBI archives Next-generation sequencing, PacBio SMRT sequencing, and Nanopore sequencing, can generate numerous sequence data in a single run. Raw reads or assembled sequence need to be submitted to public sequence repository (DDBJ/ENA/GenBank - INSDC), which is required by the overwhelming majority of journals as accession ...

ByCD Genomics


From Data to Decisions, Faster than Ever: Pioneering the future of precision medicine with the New Generation SOPHiA DDM Platform

From Data to Decisions, Faster than Ever: Pioneering the future of precision medicine with the New Generation SOPHiA DDM Platform

In response to the emerging needs in global healthcare, SOPHiA GENETICS has just revealed the New Generation SOPHiA DDM™ Platform, aiming to stay at the forefront of precision medicine and address today the healthcare needs of tomorrow. ...

BySOPHiA Genetics


Tools Used for Antibody-Drug Conjugate (ADC) Characterization

Tools Used for Antibody-Drug Conjugate (ADC) Characterization

This technique can evaluate the binding affinity, specificity, and cellular uptake of ADCs, providing essential data for preclinical and clinical studies. Surface Plasmon Resonance (SPR) SPR is a label-free technique used to study the binding interactions between the antibody and its target antigen. By providing real-time data on binding ...

ByBOC Sciences


Customer Spotlight: Laboratory of Genetics and Genomics, Cagliari

Customer Spotlight: Laboratory of Genetics and Genomics, Cagliari

We recently spoke with Manuela Badiali, Rita Congiu, and Stefania Murru from the Laboratory of Genetics and Genomics, Microcitemico Pediatric Hospital – A. Cao, Cagliari, about how SOPHiA DDM™ RNAtarget Technology has helped them optimize their variant analysis workflow. ...

BySOPHiA Genetics


Flu, COVID-19, and RSV in the U.S.: Insights from the Latest Surveillance Season

Flu, COVID-19, and RSV in the U.S.: Insights from the Latest Surveillance Season

Welcome to 2023-2024 season’s respiratory surveillance recap, where we’ll share insights from the most recent respiratory surveillance season, covering three major respiratory viruses: COVID-19, influenza, and RSV. Tracking these illnesses is imperative for maintaining population health because these illnesses significantly impact individual wellbeing and healthcare costs, resource ...

ByBiobot Analytics, Inc.


Using artificial intelligencepowered evidence-based molecular decision-making for improved outcomes in ovarian cancer

Using artificial intelligencepowered evidence-based molecular decision-making for improved outcomes in ovarian cancer

Only 20% of patients with ovarian HGSC will be long-term survivors, but no current clinical data can accurately predict which patient will be a short- or long-term survivor. ...

ByPredictive Oncology Inc.


Host Cell Protein Risks and Testing Requirements

Host Cell Protein Risks and Testing Requirements

Almost all HCPs are foreign proteins with clinical safety risks due to their potential to trigger an immune response in the body. ...

ByCreative Proteomics


Clinical Data Management: What Are The Key Challenges And How To Navigate Them?

Clinical Data Management: What Are The Key Challenges And How To Navigate Them?

One of the biggest challenges clinical data management faces is the sheer amount of data that needs to be processed. ...

ByClinion


Cracking the Code: How Small Molecules Are Revolutionizing Brain Tumor Therapy

Cracking the Code: How Small Molecules Are Revolutionizing Brain Tumor Therapy

By targeting specific pathways critical to the growth and survival of the excretory system, the scientists aim to develop more effective and less toxic treatments for brain excretory mechanisms. At the same time, pre-clinical studies are also significant to assess the efficacy and safety of small molecule drugs in brain cancer before they enter clinical trials ...

ByAlfa Cytology


From Raw Data to Actionable Insights: Biobot’s Evolution of Public Data Sharing

From Raw Data to Actionable Insights: Biobot’s Evolution of Public Data Sharing

Biobot has always believed in the transformative power of wastewater data for public health. We started by making this important data available during the COVID-19 pandemic to fill critical data gaps nationally in an easily digestible way. ...

ByBiobot Analytics, Inc.


Speeding Up Healthcare Innovation Leveraging Cloud Technology

Speeding Up Healthcare Innovation Leveraging Cloud Technology

Over the past decade, cloud computing has undergone remarkable expansion. The collective revenue generated by AWS, Google Cloud, and Microsoft surged from $49 billion in 2018 to an astonishing $206 billion in 2022.[i] Projections from Future Market Insights indicate that the revenue from cloud services is poised to maintain an impressive average annual growth rate of 21%, reaching a staggering ...

ByCaresyntax


Bispecific Antibodies and Bispecific Antibody ADCs

Bispecific Antibodies and Bispecific Antibody ADCs

Currently, bispecific ADCs are still in the early stages of development globally, with only a few products entering the clinical development stage, and all of them are in early clinical stages. ...

ByBOC Sciences


Top Advances in Echocardiography Transforming Cardiac Imaging on World Heart Day

Top Advances in Echocardiography Transforming Cardiac Imaging on World Heart Day

In honor of World Heart Day on September 29, we're diving into the world of cardiovascular diagnostics. Echocardiography, one of the most widely used screening and diagnostic modalities in healthcare, has seen a resurgence thanks to advances and groundbreaking innovations within the last few years. Join us as we explore the top trends shaping these diagnostic methods. 1. ...

ByUltromics Limited


B7-H3: Broad Prospects of Emerging Tumor Immunotherapy Targets

B7-H3: Broad Prospects of Emerging Tumor Immunotherapy Targets

Recently, in the renowned academic journal Nature Medicine, the Kimmel Cancer Center at Johns Hopkins University published Phase 2 clinical results regarding enoblituzumab, a monoclonal antibody targeting B7-H3, for the treatment of prostate cancer. ...

ByBeta Lifescience


Autoimmune Diseases Targets

Autoimmune Diseases Targets

In the treatment of severe asthma, Tezspire is the only biologic therapy without phenotype or biomarker restrictions, which indicates that more severe asthma patients have the opportunity to receive treatment. Clinical data has shown that Tezspire can significantly improve symptoms. ...

ByBeta Lifescience


ADC Drugs For HER2 Positive Breast Cancer

ADC Drugs For HER2 Positive Breast Cancer

According to the latest data, breast cancer has overtaken lung cancer to become the most common cancer among women, and the death rate is the second highest among female tumors, seriously affecting the physical and mental health of women around the world. ...

ByHunan Huateng Pharmaceutical Co. Ltd.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT